Broski SM - Search Results

1

Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma.

Charalampous C, Goel U, Broski SM, Dingli D, Kapoor P, Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Buadi F, Hwa L, Leung N, Lin Y, Gonsalves WI, Kourelis TV, Warsame R, Fonder A, Hobbs M, Binder M, Kyle RA, Rajkumar SV, Kumar SK. Charalampous C, et al. Among authors: broski sm. Blood Adv. 2022 May 10;6(9):2763-2772. doi: 10.1182/bloodadvances.2022007052. Blood Adv. 2022. PMID: 35235951 Free PMC article.

2

The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma.

Broski SM, Hunt CH, Johnson GB, Subramaniam RM, Peller PJ. Broski SM, et al. J Nucl Med. 2012 Aug;53(8):1200-6. doi: 10.2967/jnumed.112.102897. Epub 2012 Jun 22. J Nucl Med. 2012. PMID: 22728262 Free article.

3

Pigmented Villonodular Synovitis: Potential Pitfall on Oncologic 18F-FDG PET/CT.

Broski SM, Murdoch NM, Skinner JA, Wenger DE. Broski SM, et al. Clin Nucl Med. 2016 Jan;41(1):e24-31. doi: 10.1097/RLU.0000000000000893. Clin Nucl Med. 2016. PMID: 26164181

4

18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.

Broski SM, Spinner RJ, Howe BM, Dispenzieri A, Johnson GB. Broski SM, et al. Clin Nucl Med. 2016 Feb;41(2):e115-7. doi: 10.1097/RLU.0000000000000947. Clin Nucl Med. 2016. PMID: 26284768

5

BRAF Inhibitor-Induced Panniculitis: Appearance on 18F-FDG PET/CT.

Broski SM, Moran EK, Glazebrook KN, Nathan MA. Broski SM, et al. Clin Nucl Med. 2016 Mar;41(3):e149-51. doi: 10.1097/RLU.0000000000001027. Clin Nucl Med. 2016. PMID: 26447389

6

Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors.

Broski SM, Johnson GB, Howe BM, Nathan MA, Wenger DE, Spinner RJ, Amrami KK. Broski SM, et al. Skeletal Radiol. 2016 Aug;45(8):1097-105. doi: 10.1007/s00256-016-2394-7. Epub 2016 Apr 26. Skeletal Radiol. 2016. PMID: 27115884

7

Spectrum of Benign Articular and Periarticular Findings at FDG PET/CT.

White ML, Johnson GB, Howe BM, Peller PJ, Broski SM. White ML, et al. Among authors: broski sm. Radiographics. 2016 May-Jun;36(3):824-39. doi: 10.1148/rg.2016150100. Radiographics. 2016. PMID: 27163594 Review.

8

MRI of pathology-proven peripheral nerve amyloidosis.

McKenzie GA, Broski SM, Howe BM, Spinner RJ, Amrami KK, Dispenzieri A, Ringler MD. McKenzie GA, et al. Among authors: broski sm. Skeletal Radiol. 2017 Jan;46(1):65-73. doi: 10.1007/s00256-016-2510-8. Epub 2016 Oct 12. Skeletal Radiol. 2017. PMID: 27730358

9

Fibromatosis Associated With Neuromuscular Choristoma: Evaluation by FDG PET/CT.

Broski SM, Howe BM, Spinner RJ, Amrami KK. Broski SM, et al. Clin Nucl Med. 2017 Mar;42(3):e168-e170. doi: 10.1097/RLU.0000000000001508. Clin Nucl Med. 2017. PMID: 28005643

10

Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue.

Pham AQ, Broski SM, Habermann TM, Jevremovic D, Wiseman GA, Feldman AL, Maurer MJ, Ristow KM, Witzig TE. Pham AQ, et al. Among authors: broski sm. Leuk Lymphoma. 2017 Oct;58(10):2342-2348. doi: 10.1080/10428194.2017.1300891. Epub 2017 Mar 14. Leuk Lymphoma. 2017. PMID: 28290723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters